Silibinin, found in milk thistle, protects against UV-induced skin cancer – Colorado Cancer Blogs

Two University of Colorado Cancer Center studies show that silibinin protects against UVB damage and kills cells damaged by UVA — but is not at all toxic in healthy cells. Sibinin is a milk thistle extract now shown to kill skin cells mutated by UVA radiation and protects against damage by UVB radiation, potentially protecting against UV-induced skin cancer and photo-aging.

Phase III Trial of Immunotherapy Antibody Tremelimumab Versus Chemotherapy Fails to Improve Survival

Phase III trial of treatment-naive metastatic melanoma comparing tremelimumab with physician’s choice standard-of-care chemotherapy failed to show an improved overall survival for the immunotherapy antibody.

Addition of elesclomol to paclitaxel does not improve PFS in advanced melanoma patients, phase III trial shows

Results of the phase III SYMMETRY trial in stage IV metastatic melanoma patients don’t show an improvement in PFS when elesclomol was added to paclitaxel chemotherapy. But, patients with normal LDH levels did have a statistically significant improvement in median PFS for the combination therapy.